Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

BACKGROUND: Early clinical data showed that some patients with vasodilatory shock are responsive to low doses of angiotensin II. The objective of this analysis was to compare clinical outcomes in patients requiring ≤ 5 ng kg(−1) min(−1) angiotensin II at 30 min (≤ 5 ng kg(−1) min(−1) subgroup) to ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ham, Kealy R., Boldt, David W., McCurdy, Michael T., Busse, Laurence W., Favory, Raphael, Gong, Michelle N., Khanna, Ashish K., Chock, Stefan N., Zeng, Feng, Chawla, Lakhmir S., Tidmarsh, George F., Ostermann, Marlies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546778/
https://www.ncbi.nlm.nih.gov/pubmed/31161442
http://dx.doi.org/10.1186/s13613-019-0536-5

Ejemplares similares

Ejemplares similares